Company Filing History:
Years Active: 2015
Title: Sanjay Sukumar Saralaya: Innovator in Atovaquone Prodrug Development
Introduction
Sanjay Sukumar Saralaya is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrug compounds. His innovative work has led to the creation of a unique atovaquone prodrug that holds promise for enhanced therapeutic applications.
Latest Patents
Sanjay holds a patent for the compound titled "3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug." This invention relates to a process involving the condensation of Atovaquone with 5-methyl-4-chloromethyl dioxalone in a suitable solvent system. The process is designed to yield the Atovaquone prodrug in high purity and is suitable for large-scale manufacture.
Career Highlights
Sanjay is currently associated with Alkem Laboratories Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has been instrumental in advancing the company's research and development efforts.
Collaborations
Sanjay collaborates with talented coworkers, including Akshaya Kunjyannaya and Shashiprabha, who contribute to the innovative environment at Alkem Laboratories Limited.
Conclusion
Sanjay Sukumar Saralaya's contributions to the field of pharmaceuticals, particularly through his patent on atovaquone prodrug, highlight his role as an innovator. His work not only advances scientific knowledge but also has the potential to improve therapeutic outcomes for patients.